Quest Diagnostics, Inc. (DGX)
259.58
-0.07
(-0.03%)
USD |
NYSE |
Nov 13, 16:00
259.58
0.00 (0.00%)
After-Hours: 19:59
Quest Diagnostics Enterprise Value : 34.45B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 34.45B |
| November 11, 2026 | 34.34B |
| November 10, 2026 | 34.32B |
| November 09, 2026 | 34.45B |
| November 06, 2026 | 34.01B |
| November 05, 2026 | 33.91B |
| November 04, 2026 | 34.01B |
| November 03, 2026 | 33.06B |
| November 02, 2026 | 33.48B |
| October 30, 2026 | 33.59B |
| October 29, 2026 | 33.71B |
| October 28, 2026 | 32.91B |
| October 27, 2026 | 32.57B |
| October 26, 2026 | 32.61B |
| October 23, 2026 | 32.49B |
| October 22, 2026 | 32.65B |
| October 21, 2026 | 32.17B |
| October 20, 2026 | 31.97B |
| October 19, 2026 | 31.73B |
| October 16, 2026 | 31.74B |
| October 15, 2026 | 32.19B |
| October 14, 2026 | 31.56B |
| October 13, 2026 | 31.24B |
| October 12, 2026 | 31.48B |
| October 09, 2026 | 31.29B |
| Date | Value |
|---|---|
| October 08, 2026 | 31.28B |
| October 07, 2026 | 30.86B |
| October 06, 2026 | 31.01B |
| October 05, 2026 | 31.43B |
| October 02, 2026 | 31.55B |
| October 01, 2026 | 31.31B |
| September 30, 2026 | 31.52B |
| September 29, 2026 | 31.66B |
| September 28, 2026 | 32.28B |
| September 25, 2026 | 32.14B |
| September 24, 2026 | 32.16B |
| September 23, 2026 | 31.77B |
| September 22, 2026 | 31.96B |
| September 21, 2026 | 33.08B |
| September 18, 2026 | 33.25B |
| September 17, 2026 | 33.36B |
| September 16, 2026 | 33.32B |
| September 15, 2026 | 33.32B |
| September 14, 2026 | 32.31B |
| September 11, 2026 | 31.99B |
| September 10, 2026 | 31.57B |
| September 09, 2026 | 32.04B |
| September 08, 2026 | 32.04B |
| September 04, 2026 | 32.23B |
| September 03, 2026 | 32.47B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Labcorp Holdings, Inc. | 36.76B |
| Fulgent Genetics, Inc. | 401.76M |
| OPKO Health, Inc. | 1.314B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.445B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 324.00M |
| Revenue (Quarterly) | 3.097B |
| Total Expenses (Quarterly) | 2.787B |
| EPS Diluted (Quarterly) | 2.768 |
| Gross Profit Margin (Quarterly) | 32.48% |
| Profit Margin (Quarterly) | 10.46% |
| Earnings Yield | 3.87% |
| Operating Earnings Yield | 6.01% |
| Normalized Earnings Yield | 4.243 |